Rafferty Asset Management
CMD

Rafferty Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Rafferty Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,434
Closed -$836K – 607
2017
Q1 		$836K Buy
+10,434
New +$829K 0.02% 413

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Rafferty Asset Management's CMD Position: Q2 2017 in Review

Rafferty Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2017, closing a stake of 10,434 shares — an estimated $836K sold.

Rafferty Asset Management first reported a position in CMD in Q1 2017 and held it in 1 quarter. The position peaked at $836K in Q1 2017. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • Rafferty Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • Rafferty Asset Management sold 10,434 Cantel Medical Corporation shares in Q2 2017, an estimated $836K.
  • Rafferty Asset Management first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 1 quarter.
  • Rafferty Asset Management's Cantel Medical Corporation position peaked at $836K in Q1 2017.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on Rafferty Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.